Consequently, individuals carrying the GG genotype of the MDM2 SNP309 polymorphism were found to have higher MDM2 levels, which led to attenuation of the TP53 pathway and acceleration of tumor formation in humans [9]. Here, TP53 is linked to neoplasm.